Aetna Appeal Help
Aetna denies approximately 22% of claims. External reviews overturn 61% of Aetna denials. AppealArmor targets Aetna's documented vulnerabilities.
Generate Your Aetna Appeal Now -- FreeNo account required. HIPAA compliant. Takes 30 seconds.
Sources: KFF Marketplace Transparency Data, NAIC Complaint Index, CMS Enforcement Records
Aetna / CVS Health denial pattern intelligence: Aetna denies approximately 22% of in-network marketplace claims per 2023 KFF data, slightly above the 19% industry average. Since CVS Health acquired Aetna in 2018, Aetna has increasingly used CVS Caremark pharmacy benefit management to impose step therapy and formulary restrictions. Top denial categories: prior authorization (40%), medical necessity (30%), formulary/step therapy (15%), out-of-network (10%), experimental (5%).
CMO never reviewed records (Gillen deposition)
CVS Caremark conflict of interest
CMS corrective action 2024
mental health parity violations
NAIC complaint index 1.21
For medical necessity denials, reference the 2018 Gillen v. Aetna deposition where Aetna's CMO admitted to not reviewing patient records before claim decisions. Demand confirmation that a board-certified physician in the relevant specialty actually reviewed the complete medical record.
For pharmacy denials or step therapy requirements, argue CVS Health has an inherent conflict of interest because it both denies drug coverage through Aetna and profits from steering patients to CVS retail pharmacy for alternatives. Cite Metropolitan Life v. Glenn (2008) on structural conflicts.
Many states now have step therapy exception laws. If Aetna requires step therapy, check if state law allows exceptions for patients who (a) already tried and failed the required steps, (b) would experience serious harm from delay, or (c) are stable on current medication..
For MA plan denials, cite the 2024 CMS corrective action for timeliness and accuracy deficiencies..
If mental health or substance abuse claim, request the specific NQTL (non-quantitative treatment limitation) comparative analysis Aetna is required to maintain under the MHPAEA final rule. Many insurers cannot produce compliant analyses..
MA coverage determination deficiencies (CMS)
claims processing violations (Oklahoma DOI)
untimely claims processing (Connecticut DOI)
CMO record review practices (California DOI)
cancer treatment denial
network adequacy misrepresentation (California)
Upload the denial letter from Aetna. Our AI identifies the denial reason, plan type, appeal deadline, and routing.
AppealArmor uses insurer-specific intelligence to target Aetna's documented vulnerabilities, including enforcement actions totaling over $76 million in penalties, regulatory findings, and proven appeal strategies.
Your packet includes a Aetna-specific appeal letter with targeted legal citations, a state insurance commissioner complaint, and strategic CC recipients calibrated for Aetna appeals.
Aetna / CVS Health denial pattern intelligence: Aetna denies approximately 22% of in-network marketplace claims per 2023 KFF data, slightly above the 19% industry average. Since CVS Health acquired Aetna in 2018, Aetna has increasingly used CVS Caremark pharmacy benefit management to impose step therapy and formulary restrictions. Top denial categories: prior authorization (40%), medical necessity (30%), formulary/step therapy (15%), out-of-network (10%), experimental (5%).
Appealing Aetna / CVS Health denials -- proven strategies: AppealArmor generates a targeted appeal letter with insurer-specific legal citations, enforcement history, and regulatory references.
Aetna / CVS Health enforcement and regulatory history: 2024 -- CMS audit identified deficiencies in Aetna Medicare Advantage coverage determination timeliness and accuracy; corrective action required. 2023 -- Oklahoma Insurance Department fined Aetna $4.3 million for claims processing violations. 2020 -- Connecticut Insurance Department (Aetna's home state) imposed $1.
Aetna has a NAIC complaint index of 1.21, which is 21% above the national average of 1.0. This publicly available metric measures complaint volume relative to market share and can be cited in appeals and regulatory complaints.
Yes. AppealArmor maintains detailed intelligence on Aetna including denial patterns, enforcement history, known regulatory vulnerabilities, and proven appeal strategies. Your appeal letter will include Aetna-specific legal citations and references to relevant enforcement actions.
Upload your Aetna denial and get a professionally written appeal targeting Aetna's specific vulnerabilities with court rulings, regulatory citations, and insurer intelligence.
Generate Your Appeal Now -- Free